🇺🇸 FDA
Company

Vor

Vor Biopharma

VOR biotech USA

Quick answer

Vor is a biotech company (VOR) headquartered in BOSTON, MA, USA with 5 tracked pipeline programs.

Pipeline (5)

project

Telitacicept

Generalized Myasthenia Gravis

Phase 3 · mab · active

1 trials project

Telitacicept

Primary Sjogren's Disease

Phase 3 · mab · active

1 trials project

Telitacicept

Systemic Lupus Erythematosus

Phase 3 · mab · terminated

2 trials project

VCAR33

Leukemia, Myeloid, Acute

Phase 2 · mab · terminated

1 trials project

VOR33

Leukemia, Myeloid, Acute

Phase 2 · mab · terminated

1 trials

Patents (8)

patent

US 12403200

Methods and compositions for treating autoimmune diseases

Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12291576

Anti-CD45 antibodies and conjugates thereof

Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12251403

Genetically engineered hematopoietic stem cells and uses thereof

Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12209135

Anti-CD45 antibodies and conjugates thereof

Expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11975029

Compositions and methods for inhibition of lineage specific proteins

Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11903973

Genetically engineered hematopoietic stem cells and uses thereof

Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11571445

Genetically engineered hematopoietic stem cells and uses thereof

Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11559551

Genetically engineered hematopoietic stem cells and uses thereof

Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)